Dianthus Therapeutics Inc. Earnings

The next earnings date for Dianthus Therapeutics Inc. has not yet been scheduled.

Analyst Estimates of Dianthus Therapeutics Inc. Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Dianthus Therapeutics Inc. Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/07/2025	Before Market	$-0.82	-15.49%
03/19/2025	Before Market	$-0.81	-6.58%
11/07/2024	After Market	$-0.72	-22.03%
08/08/2024	After Market	$-0.51	7.27%
05/09/2024	After Market	$-0.54	-22.73%
03/21/2024	After Market	$-0.71	29.70%
11/09/2023	After Market	$-3.78	-575.00%
09/18/2023	---	$-0.87	71.50%
05/11/2023	---	$-0.47	-17.50%
03/07/2023	---	$-0.30	-8.62%
11/03/2022	---	$-0.27	6.90%
08/04/2022	---	$-0.29	14.71%
05/16/2022	---	$-0.39	-22.60%
03/08/2022	---	$-0.33	-4.13%
11/04/2021	---	$-0.30	8.68%
08/05/2021	---	$-0.32	14.09%
05/06/2021	---	$-0.36	7.22%
03/03/2021	---	$-0.38	2.06%
11/05/2020	---	$-0.37	13.95%
08/06/2020	---	$-0.48	11.11%
05/07/2020	---	$-0.51	15.00%
03/03/2020	---	$-0.59	-1.72%
11/13/2019	---	$-0.54	-1.89%
08/08/2019	---	$-0.48	2.04%
05/09/2019	---	$-0.44	20.00%
03/19/2019	---	$-0.50	5.66%
11/08/2018	---	$-0.49	26.87%
08/09/2018	---	$-3.13	-176.99%
05/30/2018	---	$-4.45	---
02/03/2018	---	$-1.03	---
05/04/2017	---	$-0.15	---

More About Dianthus Therapeutics Inc.

Website

https://dianthustx.com

Country

USA

Full Time Employees

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. The company's lead novel and proprietary monoclonal antibody product candidate includes DNTH103, a human monoclonal immunoglobulin G4 with picomolar that binds the active form of C1s, which is in clinical-stage trials for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

“Dianthus Therapeutics Inc. Earnings” Can Refer to the Dianthus Therapeutics Inc. Earnings Date

Some people say “Dianthus Therapeutics Inc. earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Dianthus Therapeutics Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Dianthus Therapeutics Inc. Stock on the Earnings Date

If you own Dianthus Therapeutics Inc. stock (DNTH) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Dianthus Therapeutics Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Dianthus Therapeutics Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Dianthus Therapeutics Inc. Earnings

You can contact us any time if you would like to ask questions about Dianthus Therapeutics Inc. earnings or anything else related to the stock market.